Engineers Gate Manager LP Raised Its Commscope Hldg Co (COMM) Stake, Boston Scientific (BSX) Had 21 Bullish Analysts

July 17, 2017 - By Nellie Frank

Among 27 analysts covering Boston Scientific Corporation (NYSE:BSX), 21 have Buy rating, 0 Sell and 6 Hold. Therefore 78% are positive. Boston Scientific Corporation had 48 analyst reports since July 27, 2015 according to SRatingsIntel. RBC Capital Markets maintained Boston Scientific Corporation (NYSE:BSX) rating on Friday, June 9. RBC Capital Markets has “Outperform” rating and $31 target. On Thursday, April 28 the stock rating was maintained by RBC Capital Markets with “Outperform”. The company was downgraded on Monday, May 23 by BTIG Research. The rating was maintained by Jefferies on Tuesday, June 27 with “Hold”. Needham maintained the stock with “Buy” rating in Friday, April 28 report. Argus Research upgraded the shares of BSX in report on Thursday, September 1 to “Buy” rating. The firm earned “Hold” rating on Monday, June 26 by BTIG Research. The firm earned “Neutral” rating on Thursday, April 28 by Wedbush. The stock of Boston Scientific Corporation (NYSE:BSX) has “Buy” rating given on Thursday, November 12 by Citigroup. The firm earned “Buy” rating on Wednesday, June 28 by Barclays Capital. See Boston Scientific Corporation (NYSE:BSX) latest ratings:

10/07/2017 Broker: RBC Capital Markets Rating: Buy New Target: $31.0000 Maintain
28/06/2017 Broker: Barclays Capital Rating: Buy New Target: $31.0000 Maintain
28/06/2017 Broker: Oppenheimer Rating: Hold Maintain
27/06/2017 Broker: Jefferies Rating: Hold New Target: $28.0000 Maintain
28/06/2017 Broker: Stifel Nicolaus Rating: Buy New Target: $32.0000
28/06/2017 Broker: Needham Rating: Buy New Target: $32.0000 Maintain
26/06/2017 Broker: BTIG Research Rating: Hold Maintain
19/06/2017 Broker: BMO Capital Markets Rating: Buy New Target: $30.0000 Maintain
22/06/2017 Broker: Needham Rating: Buy Old Target: $30.00 New Target: $32.00 Maintain
16/06/2017 Broker: Wells Fargo Rating: Outperform Old Target: $29.50 New Target: $31.00 Target Up

Engineers Gate Manager Lp increased Commscope Hldg Co Inc (COMM) stake by 70.39% reported in 2016Q4 SEC filing. Engineers Gate Manager Lp acquired 47,504 shares as Commscope Hldg Co Inc (COMM)’s stock declined 6.21%. The Engineers Gate Manager Lp holds 114,990 shares with $4.28M value, up from 67,486 last quarter. Commscope Hldg Co Inc now has $6.64B valuation. The stock declined 0.54% or $0.19 reaching $34.94 on the news. About 1.66 million shares traded. Commscope Holding Company Inc (NASDAQ:COMM) has risen 25.42% since July 17, 2016 and is uptrending. It has outperformed by 8.72% the S&P500.

Investors sentiment decreased to 1.62 in Q4 2016. Its down 0.42, from 2.04 in 2016Q3. It dived, as 26 investors sold COMM shares while 75 reduced holdings. 72 funds opened positions while 92 raised stakes. 186.02 million shares or 3.27% less from 192.31 million shares in 2016Q3 were reported. Delphi Mngmt Inc Ma invested 0.31% of its portfolio in Commscope Holding Company Inc (NASDAQ:COMM). Washington Tru Bank & Trust invested in 19 shares or 0% of the stock. First Quadrant Limited Partnership Ca has 159,260 shares for 0.12% of their portfolio. Hutchin Hill Cap Lp holds 0.32% or 248,800 shares. Jefferies Grp Lc stated it has 16,043 shares or 0% of all its holdings. Ibm Retirement Fund has invested 0.02% in Commscope Holding Company Inc (NASDAQ:COMM). Daiwa Securities Group holds 0.03% of its portfolio in Commscope Holding Company Inc (NASDAQ:COMM) for 108,000 shares. Menta Capital Limited Liability, a California-based fund reported 108,043 shares. Reilly Ltd Liability Com has invested 0% in Commscope Holding Company Inc (NASDAQ:COMM). Columbus Circle Investors owns 1.56 million shares for 0.76% of their portfolio. Clear Harbor Asset Ltd Co reported 0.44% of its portfolio in Commscope Holding Company Inc (NASDAQ:COMM). Silver Limited Liability Corporation invested in 11,540 shares. Peak6 Investments Limited Partnership holds 0.01% or 23,309 shares in its portfolio. 6,555 were accumulated by Cfo4life Limited Partnership. Makaira Ltd Liability has invested 10.59% of its portfolio in Commscope Holding Company Inc (NASDAQ:COMM).

Among 11 analysts covering CommScope Holding (NASDAQ:COMM), 8 have Buy rating, 0 Sell and 3 Hold. Therefore 73% are positive. CommScope Holding had 21 analyst reports since July 24, 2015 according to SRatingsIntel. Goldman Sachs reinitiated the stock with “Neutral” rating in Friday, September 18 report. The stock of Commscope Holding Company Inc (NASDAQ:COMM) earned “Market Perform” rating by Northland Capital on Tuesday, November 10. The firm earned “Overweight” rating on Tuesday, November 10 by Barclays Capital. The stock of Commscope Holding Company Inc (NASDAQ:COMM) has “Buy” rating given on Monday, February 22 by Cross Research. The company was downgraded on Tuesday, January 17 by Raymond James. The firm has “Buy” rating given on Tuesday, December 20 by Citigroup. The rating was maintained by Jefferies on Tuesday, June 6 with “Buy”. Northland Capital initiated Commscope Holding Company Inc (NASDAQ:COMM) rating on Wednesday, September 30. Northland Capital has “Market Perform” rating and $25 target. The rating was initiated by Morgan Stanley with “Equal-Weight” on Tuesday, September 20. As per Friday, June 17, the company rating was initiated by BTIG Research.

Engineers Gate Manager Lp decreased Kb Home (NYSE:KBH) stake by 120,699 shares to 34,988 valued at $553,000 in 2016Q4. It also reduced National Oilwell Varco Inc (NYSE:NOV) stake by 48,805 shares and now owns 14,413 shares. Sysco Corp (NYSE:SYY) was reduced too.

About 1.73 million shares traded. Boston Scientific Corporation (NYSE:BSX) has risen 19.12% since July 17, 2016 and is uptrending. It has outperformed by 2.42% the S&P500.

Boston Scientific Corporation is a developer, maker and marketer of medical devices that are used in a range of interventional medical specialties. The company has market cap of $38.01 billion. The Firm offers its products by seven businesses: Interventional Cardiology, Cardiac Rhythm Management, Endoscopy, Peripheral Interventions, Urology and Pelvic Health, Neuromodulation, and Electrophysiology. It has a 88.01 P/E ratio. It operates in three divisions: Cardiovascular, Rhythm Management and MedSurg.

Investors sentiment decreased to 0.84 in Q4 2016. Its down 0.28, from 1.12 in 2016Q3. It is negative, as 67 investors sold Boston Scientific Corporation shares while 195 reduced holdings. 60 funds opened positions while 161 raised stakes. 1.23 billion shares or 1.80% more from 1.21 billion shares in 2016Q3 were reported. Hsbc Hldgs Public Ltd Com holds 809,380 shares or 0.04% of its portfolio. Moreover, Legal & General Gp Inc Public Ltd Com has 0.12% invested in Boston Scientific Corporation (NYSE:BSX) for 6.13 million shares. Benjamin F Edwards accumulated 300 shares or 0% of the stock. Jefferies Grp Inc Lc has 52,274 shares for 0.01% of their portfolio. Nottingham Advisors owns 31,786 shares or 0.12% of their US portfolio. Jag Cap Limited Liability Co holds 0.23% of its portfolio in Boston Scientific Corporation (NYSE:BSX) for 53,000 shares. Crestwood Ltd Limited Liability Company accumulated 10,950 shares. Bluemountain holds 0.02% or 48,224 shares. Riverhead Cap Mngmt reported 209,833 shares. Highland Capital Management stated it has 10,550 shares or 0.02% of all its holdings. Bnp Paribas Investment Prtn reported 2.74M shares stake. 113,500 were reported by Sio Cap Management Limited Liability. 56,700 were reported by First Mercantile Trust. Moreover, Lpl Ltd has 0.02% invested in Boston Scientific Corporation (NYSE:BSX) for 96,684 shares. Pioneer Invest Mgmt, a Massachusetts-based fund reported 1.94 million shares.

Since February 6, 2017, it had 0 insider buys, and 18 selling transactions for $10.25 million activity. The insider Pierce David A sold 3,417 shares worth $84,883. 28,864 shares were sold by Ballinger Kevin J., worth $754,454 on Wednesday, May 17. Phalen Michael P. sold 79,045 shares worth $1.94M. Dawkins Keith D also sold $2.04M worth of Boston Scientific Corporation (NYSE:BSX) on Tuesday, February 7. On Monday, February 6 Thepaut Eric Francis Yves sold $592,858 worth of Boston Scientific Corporation (NYSE:BSX) or 23,775 shares. Pratt Timothy A. sold $248,725 worth of Boston Scientific Corporation (NYSE:BSX) on Monday, April 3. The insider Sorenson John Bradley sold 2,950 shares worth $72,747.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.





Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: